Jeng-shiun W. Du
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Transcriptomic Profiling Identifies Higher DOT1L Expression as a Candidate Biomarker for a Positive Response to Gemcitabine in Cholangiocarcinoma.
Journal: Cancer genomics & proteomics
Published: March 02, 2026
Baseline FDG PET/CT SUVmax predicts POD24 and progression-free survival in newly diagnosed follicular lymphoma.
Journal: Annals of nuclear medicine
Published: February 12, 2026
Immunotherapy Response Predictive Score Based on Tumor Microenvironment Profiles for Predicting Immunotherapy Outcomes in Advanced Head and Neck Cancer.
Journal: Technology in cancer research & treatment
Published: January 23, 2026
A New CA19-9 Cutoff Value Identifies Lewis Antigen Status and Refines Prognostic Stratification in PDAC.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 30, 2025
Targeting lncRNA MALAT1 attenuates lenalidomide resistance via CD38 epigenetic modulation, oxidative stress-mediated cell death, and remodeling of the pro-tumor microenvironment in multiple myeloma.
Journal: Journal of translational medicine
Published: July 31, 2025
The Epidemiology of Neuroendocrine Carcinomas in Taiwan: A Population-Based Cancer Registry Study.
Journal: Cancer medicine
Published: January 14, 2025
Biomarker potential of nuclear Nrf2 activation in the ABC subtype of diffuse large B‑cell lymphoma.
Journal: Oncology letters
Published: July 26, 2024
The Current and Prospective Adjuvant Therapies for Hepatocellular Carcinoma.
Journal: Cancers
Published: February 26, 2024
Analysis of 9 cases of pediatric-type follicular lymphoma
Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: November 29, 2023
Prognostic mutation signature would serve as a potential prognostic predictor in patients with diffuse large B-cell lymphoma.
Journal: Scientific reports
Published: November 09, 2023
A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study.
Journal: The oncologist
Published: September 29, 2023
Serological Responses and Predictive Factors of Booster COVID-19 Vaccines in Patients with Hematologic Malignancies.
Journal: Journal of clinical medicine
Published: June 16, 2023
Last Updated: 09/26/2026